. Citigroup Upgrades Alexion Pharma to Buy from Hold
Alexion Pharmaceuticals, Inc.(Nasdaq GM: ALXN) has been upgraded. Citigroup has raised its target on shares to $55 from $45
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.